Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Nonhormonal therapies transform menopause care in 2025
2
Prenatal hydroxyurea shows no adverse pregnancy outcomes
3
Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more
4
GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections
5